The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an mRNA vaccine for flu strains with pandemic potential, including bird flu.

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

How a bird flu pandemic could emerge 06:21. The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United States is in the midst of an ...

From the outset of the Trump administration, bird flu, or H5N1 avian influenza, has flown rather conspicuously — and in fact ...

While H5N1 does not have high mortality rates in dairy cows, the infection causes decreases milk production and milk quality, ...

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which ...

This vaccine showed 100% protection in mice studies against a lethal H5N1 bird flu strain. BUFFALO, N.Y. — Scientists in Buffalo are behind a major breakthrough in the fight against avian flu.

The shift reflects the current public health situation, marked by declines in human cases as well as animal detections.

This vaccine showed 100% protection in mice studies against a lethal H5N1 bird flu strain. Researchers in Buffalo develop nanoparticle-based vaccine offering full protection in mice against lethal ...